CHAP trial awarded Clinical Trial of the Year

by Hannah Echols, UAB News, May 24, 2023

Alan T. Tita, M.D., Ph.D.
Alan Tita, M.D., Ph.D.,

The Chronic Hypertension and Pregnancy trial, led by the University of Alabama at Birmingham, received the David Sackett Trial of the Year award from the Society for Clinical Trials. The prestigious award is given to a clinical trial that improves the lot of humankind and provides substantial and beneficial change to health care.

The CHAP trial evaluated the effects of prescribing blood pressure medication to pregnant women with mild chronic hypertension. Results published in the New England Journal of Medicine in April 2022 showed treatment improved pregnancy outcomes without compromising the baby’s growth and overall health, which was a primary concern for physicians for years. CHAP results have since led to changes in national guidelines.

“Chronic hypertension causes serious and life-threatening complications for pregnant women and their babies,” said Alan Tita, M.D., Ph.D., professor of obstetrics and gynecology in the UAB Marnix E. Heersink School of Medicine, principal investigator for the CHAP trial, and lead author of the NEJM paper. “Between 70 percent and 80 percent of pregnant women with chronic hypertension fall into the ‘mild’ category, where there was not a medical consensus for treatment.”

The CHAP consortium — including over 60 collaborating clinical sites across the United States, with clinical and data coordinating centers in the UAB departments of Obstetrics and Gynecology and Center for Women’s Reproductive Health and the department of Biostatistics in the School of Public Health — launched the CHAP program in 2014 with funding from the National Institutes of Health’s Heart, Lung and Blood Institute. From September 2015 to March 2021, CHAP enrolled more than 2,400 pregnant women with mild chronic hypertension whose blood pressure was greater than 140/90 mmHg but less than 160/105 mmHg.

Alan Tita, MD, PhD wins the Herb Pardes Award

UAB, May 1, 2023

Herb Pardes Award

Congratulations to Alan Tita, whose CHAP study was selected as the top and most impactful study at TS23 Clinical Research Forum, and earning the prestigious Herbert Pardes Clinical Research Excellence Award! Tita’s work joins studies from IH, University of Chicago, MGH, Hopkins, Yale, UC Davis, and Cleveland Clinic selected as the top 10 studies this year.

Tita and Team to Receive 2023 Top Ten Clinical Research Achievement Award from the Clinical Research Forum

UAB, CCTS, February 27, 2023

The research team led by Alan Tita, MD, PhD, will be honored with a 2023 Top Ten Clinical Research Achievement Award by the Clinical Research Forum (CR Forum) at a ceremony in Washington, D.C. on April 17, 2023. Dr. Tita is the senior vice chair for Research and Innovation in the UAB Department of Obstetrics and Gynecology, associate dean for Global and Women’s Health at the UAB Heersink School of Medicine, and director of the UAB Center for Women’s Reproductive Health. He is a CCTS Co-Investigator for Maternal/Fetal Medicine.

Alan T. N Tita, M.D., Ph.D.
Alan T. N Tita, M.D., Ph.D.

The Top 10 Clinical Research Achievement Awards honor groundbreaking achievements in clinical research from across the nation. The competition seeks to identify major advances in the biomedical field resulting from the nation’s investment in health and welfare. The Top 10 award recipients are selected by a CR Forum panel from among clinical research studies published in peer-reviewed journals in 2022. They are based on the degree of innovation and novelty involved in the advancement of science; contribution to the understanding of human disease and/or physiology; and potential impact upon the diagnosis, prevention, and/or treatment of disease.

Tita is being honored for his leadership in the CHAP (Chronic Hypertension and Pregnancy) study, the most comprehensive trial of chronic hypertension in pregnancy ever undertaken. “The Chronic CHAP trial addressed a decades’ old question regarding not only the safety but benefits of treating chronic hypertension during pregnancy and led to immediate changes in national guidelines” said Tita. “This award recognizes the power of clinical research and collaboration that took literally more than a village. I am grateful to the CR Forum and to all the investigators, staff, healthcare workers and of course the patients that made this trial successful.”

“The Top 10 Clinical Research Achievement Awards honor and celebrate the innovation, tireless efforts and profound contributions that clinical researchers and advocates have made on the health and wellness of humanity,” said Harry P. Selker, MD, MSPH, Chair of the CR Forum and Dean, Tufts Clinical and Translational Science Institute at Tufts University. “We congratulate the 2023 winners for their outstanding efforts.”

CHAP trial named a Notable Article of 2022 by the NEJM

The Heersink School of Medicine, Written by Shawna Masters, January 25, 2023

Pregnancy

The UAB-led Chronic Hypertension and Pregnancy (CHAP) trial has been named one of the New England Journal of Medicine’s (NEJM) Notable Articles of 2022.

Each year, NEJM editors select a collection of articles to be recognized as “notable” from the previous year. Many of the 2022 articles selected received extensive news coverage, one being the CHAP trial.

The CHAP trial, led by principal investigator Alan Tita, M.D., Ph.D., was initially published in the NEJM in April 2022. The study provides, for the first time, evidence that treating mild chronic hypertension with medications is both safe and beneficial for the mother and the baby.

Tita inducted into National Academy of Medicine

Written by Shawna Masters, Heersink School of Medicine News, October 21, 2022

Alan T. Tita, M.D., Ph.D.

Alan T. Tita, M.D., Ph.D., professor and senior vice chair of Research and Innovation in the Department of Obstetrics and Gynecology (OB/GYN), has been elected to the National Academy of Medicine (NAM).

Induction into NAM is considered one of the highest honors in health and medicine. Membership within the Academy recognizes those who have made major contributions to advance health care, medical sciences, and public health and have demonstrated a dedication to service.

“I am thankful to the Academy and the members who nominated me for this recognition,” says Tita. “This is the result of the support of our department and institution and extensive collaborations.”

The Academy specifically praised Tita as “an innovative and impactful perinatal epidemiologist and clinical trialist.” They noted his leadership of “large, collaborative, multi-center national and international trials and observational studies that have shifted practice and policy and improved the quality of national and global obstetric care.”

Tita, who was recently named the Mary Heersink Endowed Chair in Global Health, also serves as associate dean for Global and Women’s Health and director of the Center for Women’s Reproductive Health at UAB.

“This is amazing and humbling,” says Tita. “I have benefitted from the support and collaboration of so many colleagues and mentors. This is crucial for successful clinical research, and I think this honor rewards that collaboration.”

In 2022, alone, Tita led the groundbreaking Chronic Hypertension and Pregnancy (CHAP) trial that was published in the New England Journal of Medicine, and he was selected to lead the Coordinating Center of the P3 (Pregnancy and Postpartum/Postnatal) EQUATE (Enhancing Access and QUAlity To Achieve Equitable Maternal and Infant Health) Network.